We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
-4.77%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$804M
AUM Growth
-$60M
Cap. Flow
+$17.5M
Cap. Flow %
2.18%
Top 10 Hldgs %
81.16%
Holding
47
New
2
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GRAB icon
Grab
GRAB
+$11.9M
2
KITT icon
Nauticus Robotics
KITT
+$4.43M
3
LAUR icon
Laureate Education
LAUR
+$1.15M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Communication Services 47.87%
2 Healthcare 20.16%
3 Consumer Discretionary 14.29%
4 Technology 12.36%
5 Industrials 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$3.91T
$231M 28.7%
2,411,540
– –
META icon
2
Meta Platforms (Facebook)
META
$1.51T
$154M 19.18%
1,135,916
– –
LNW
3
DELISTED
Light & Wonder
LNW
$115M 14.29%
2,678,571
– –
ABCL icon
4
AbCellera Biologics
ABCL
$1.62B
$40.6M 5.05%
4,105,095
– –
EQRX
5
DELISTED
EQRx, Inc. Common Stock
EQRX
$26M 3.24%
5,262,161
– –
GRAB icon
6
Grab
GRAB
$13.5B
$24.5M 3.04%
9,301,490
+3,931,571
+73% +$11.9M
PCT icon
7
PureCycle Technologies
PCT
$1.17B
$20.2M 2.51%
2,498,170
– –
RXRX icon
8
Recursion Pharmaceuticals
RXRX
$1.57B
$16.1M 2%
1,509,254
– –
RVMD icon
9
Revolution Medicines
RVMD
$40.2B
$13.2M 1.64%
670,382
– –
RLAY icon
10
Relay Therapeutics
RLAY
$4.02B
$12.1M 1.51%
541,124
– –
PLRX icon
11
Pliant Therapeutics
PLRX
$67.5M
$11.7M 1.46%
562,379
– –
MEKA
12
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$9.87M 1.23%
1,000,000
– –
ASML icon
13
ASML
ASML
$675B
$8.38M 1.04%
20,186
– –
QRVO icon
14
Qorvo
QRVO
$7.63B
$8.31M 1.03%
104,669
– –
NVDA icon
15
NVIDIA
NVDA
$5.01T
$8.06M 1%
663,680
– –
ADI icon
16
Analog Devices
ADI
$181B
$7.6M 0.95%
54,568
– –
TSM icon
17
TSMC
TSM
$2.09T
$7.36M 0.92%
107,294
– –
AMAT icon
18
Applied Materials
AMAT
$426B
$7.25M 0.9%
88,443
– –
AMD icon
19
Advanced Micro Devices
AMD
$851B
$7.11M 0.88%
112,137
– –
LRCX icon
20
Lam Research
LRCX
$382B
$7M 0.87%
191,310
– –
KNTE
21
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$5.95M 0.74%
498,001
– –
MU icon
22
Micron Technology
MU
$1.04T
$5.39M 0.67%
107,522
– –
INTC icon
23
Intel
INTC
$466B
$5.35M 0.67%
207,752
– –
TXG icon
24
10x Genomics
TXG
$5.87B
$5.3M 0.66%
186,143
– –
NRIX icon
25
Nurix Therapeutics
NRIX
$2.43B
$4.1M 0.51%
314,762
– –
1
2

Similar funds

DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
DE
Diversified Enterprises Wilmington, Delaware $1.83B AUM 16.79% 1-Year Est. Return
SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Harvard Management Company's Q3 2022 Portfolio in Review

As of Q3 2022, Harvard Management Company held 47 positions worth $804M, down 6.9% from $864M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 4.3%. Harvard Management Company opened 2 new positions and made no exits, leaving the 47-position portfolio largely intact.

By sector, the portfolio is most concentrated in Communication Services at 48% of assets, down from 52% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Harvard Management Company's largest Q3 2022 buy was Nauticus Robotics: 193 shares worth $1.8M.
  • Harvard Management Company added most to Grab in Q3 2022, an estimated $11.9M increase.
  • Harvard Management Company's ten largest holdings make up 81% of its $804M portfolio in Q3 2022.
  • Harvard Management Company opened 2 new positions and closed 0 in Q3 2022.
  • Harvard Management Company's portfolio value fell 6.9% quarter-over-quarter to $804M.

Based on Harvard Management Company's 13F filing for Q3 2022, filed 10 Nov 2022.